Smart Calls with Smartkarma | The Medline IPO: Big Scale, Big Risks

Medline, one of the largest suppliers of everyday medical and surgical essentials is heading for what could be the biggest US IPO of 2025, with a potential $5.4B raise and heavyweight cornerstone investors on board.

Jeff Zell joins Pranav Rao to break down:

• What makes Medline a "backbone" player in US healthcare

• Key details of the IPO structure and cornerstone participants

• Why size, leverage, and timing create real risks

• The challenges of pricing a deal with 49 underwriters

Like what you heard? Share this episode and follow us for more Smart Calls.

Read the full Insight - https://skr.ma/C7S7k

IPO Boutique - https://on.skr.ma/44ETWnZ

This podcast is provided for general informational and entertainment purposes only, and is not intended to provide financial, investment or other professional advice. Views expressed by third parties do not necessarily represent Smartkarma’s views. Smartkarma assumes no responsibility or liability for the accuracy, compliance or completeness of the podcast or the information it contains. Users should not rely on the podcast or the information it contains when making individual, business or other strategic decisions and should always consult a qualified expert or professional adviser.